Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.23.2
SHARE CAPITAL (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

   

June 30,

2023

   

June 30,

2022

 
Warrants     13,537,969       9,876,680  
Options     1,339,024       641,730  
Convertible debentures     45,250,548       6,317,567  
Total anti-dilutive weighted average shares     60,127,541       16,835,977